The firm recorded Q4 oncology revenues of $4.06 billion compared to $3.19 billion in the same period last year.

Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...

The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which ...

H.C. Wainwright analyst Emily Bodnar increased the price target for Briacell Therapeutics (NASDAQ:BCTX) to $32 from the previous $15, while maintaining a Buy rating on the stock. The company, ...

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and ...

On World Cancer Day, let us take a look at the Bollywood celebrities who have fought the deadly disease and emerged ...

This World Cancer Day 2025 take inspiration from Bollywood stars like Sonali Bendre Sanjay Dutt and Manisha Koirala who bravely fought cancer and emerged victorious Read ahead to know more ...

On the notable occasion of World Cancer Day 2025, let’s celebrate Bollywood celebrities who bravely fought and triumphed over ...

During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...

January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.